Video: Find Solutions to Help Treat Bovine Respiratory Disease the First Time
Success in bovine respiratory disease treatments positively impacts other areas of the operation
Watch this short video to hear more tips for treating BRD right the first time from Doug Hilbig, DVM, Beef Technical Services at Zoetis, Clark Price, owner at River Ranch, and other producers and veterinarians.
Bovine respiratory disease (BRD) is a costly disease for the cattle industry, and when it isn’t treated effectively it can lead to repulls and increased treatment and labor costs. Respiratory tract damage can also compromise animal performance for the rest of the feeding period.
There are two questions to ask when thinking about BRD management: First and foremost, what can we do to keep that animal healthy, and second, how do we get the highest treatment success when we do have to treat the animal?
“The earlier we can intervene into a disease process, the better,” said Doug Hilbig, DVM, Beef Technical Services, Zoetis, “Think about all of the things that we can do the first day we own that calf to prevent it from ever having a problem.”
Including a veterinarian to assist with BRD management can help bring success to the health and well-being of cattle and the operation, Dr. Hilbig says. Using a product that helps to protect against all BRD-causing pathogens will also help protect against this costly disease.
“The veterinarian is a crucial part of your operation,” said Clark Price, owner at River Ranch, Hensler, North Dakota. “At our operation, we’re taking care of the animals in the best way that we can do it. The cattle I buy usually are directly off the cow, so they’re needing a little extra care.”
Successful BRD treatments can have a positive impact across the entire operation. For more about this, watch this video or speak to your veterinarian or Zoetis representative about BRD Solutions.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.
For more information, contact:
Leona Ling Ferguson
- Belgium (French)
- Belgium (Dutch)
- Costa Rica
- Czech Republic
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States